Overview
The Information Commissioner’s Office (ICO) published new draft guidance on the provisions in the UK General Data Protection Regulation and Data Protection Act 2018 (collectively, the UK GDPR) relating to processing personal data for research purposes.
The guidance provides clarity to health and life sciences companies and will be broadly welcomed in an area that is often difficult to navigate, not least because the law is contained in various provisions and there has been varying guidance on how to interpret the provisions.
McDermott’s Health partner Sharon Lamb and trainee Michaela Novakova explain the details of the proposal in an article published in Health Tech World.
